Alemtuzumab induction therapy in kidney transplantation: a systematic review and meta-analysis.
BACKGROUND: Alemtuzumab (MabCampath or Campath; Genzyme, Cambridge, MA) is a CD52-specific monoclonal antibody that causes profound and sustained lymphocyte depletion. Its use as an induction therapy in organ transplantation is increasing. Since our last systematic review in 2006, where we identifi...
Príomhchruthaitheoirí: | Morgan, R, O'Callaghan, J, Knight, SR, Morris, P |
---|---|
Formáid: | Journal article |
Teanga: | English |
Foilsithe / Cruthaithe: |
2012
|
Míreanna comhchosúla
Míreanna comhchosúla
-
Systematic reviews of alemtuzumab in renal transplantation.
de réir: O'Callaghan, J, et al.
Foilsithe / Cruthaithe: (2013) -
Systematic reviews of alemtuzumab in renal transplantation
de réir: O'Callaghan, J, et al.
Foilsithe / Cruthaithe: (2013) -
Systematic review and meta-analysis of hypothermic machine perfusion versus static cold storage of kidney allografts on transplant outcomes.
de réir: O'Callaghan, J, et al.
Foilsithe / Cruthaithe: (2013) -
Preservation solutions for static cold storage of kidney allografts: A systematic review and meta-analysis
de réir: O'Callaghan, J, et al.
Foilsithe / Cruthaithe: (2012) -
Preservation solutions for static cold storage of kidney allografts: a systematic review and meta-analysis.
de réir: O'Callaghan, J, et al.
Foilsithe / Cruthaithe: (2012)